Navigation Links
Fat-Burning Chemical Points to New Weight-Loss Drug
Date:2/2/2010

Results of lab tests with mice suggest promising new direction for research, scientists say

TUESDAY, Feb. 2 (HealthDay News) -- American scientists say they may have found a new way to trick the body into burning more fat.

Mice that were given a chemical that blocks the function of an enzyme called Fyn kinase burned more fatty acids and expended more energy, which made them leaner. This and other metabolic improvements, including increased insulin sensitivity, were because of higher levels of the "master energy switch" AMPK in the rodents' fat and muscle tissue.

The findings suggest that Fyn kinase may offer a target for a new kind of weight-loss drug, said the researchers at the Albert Einstein College of Medicine and Neuroscience. The study appears in the Feb. 3 issue of the journal Cell Metabolism.

"When there is an imbalance between what we eat and what we burn," the result is obesity, team leader Claire Bastie said in a news release from the journal. "And the problem of obesity is not going away. This is a new mechanism to help the body burn extra energy."

The experimental drug used to block Fyn kinase in the mice isn't an ideal candidate for clinical trials in humans because both Fyn kinase and AMPK have effects in the brain as well as in fat and muscle.

"Our next goal is to design [a drug] extremely specific to muscle and [fat]," Bastie said.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about weight loss.



-- Robert Preidt



SOURCE: Cell Press, news release, Feb 2, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Pacific Shore Holdings, Inc. Launches Burner Balm a Revolutionary, Energy-Boosting, Appetite-Suppressing, Fat-Burning Lip Balm - Natural, Green and Cost-Effective - Featured on NBCs Today Show
2. Impaired fat-burning gene worsens diabetes
3. Mount Sinai finds prenatal exposure to certain chemicals affects childhood neurodevelopment
4. Biochemical profile may help diagnose, determine aggressiveness of prostate cancer
5. Flame-Retardant Chemical Linked to Conception Problems
6. Poop dermatitis linked to fashionable toilet seats, harsh chemicals
7. Stain repellent chemical linked to thyroid disease in adults
8. FDAs BPA Announcement an About Face on the Toxic Chemical
9. Chemical BPA Linked to Heart Disease Risk
10. Breast Growth in Boys Might Be Linked to Plastics Chemical
11. When Will FDA Speak Out on Toxic Plastics Chemical BPA?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 26, 2017 , ... Leading CEOs from biotech, pharmaceutical, and ... 31st at The Four Seasons Hotel Boston. , The Boston CEO Conference ... exclusive access to key decision makers who influence deal making and investment. Attendees ...
(Date:5/26/2017)... ... 26, 2017 , ... Somnoware, a leading provider of digital ... its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration ... platform, initializing devices and importing studies are just one-click operations. This plugin streamlines ...
(Date:5/26/2017)... ... May 26, 2017 , ... via ... antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie Copper ... thrilled to partner with Cupron® to provide customers with a game changing chair ...
(Date:5/26/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... Peace Agreements being discussed by President Donald Trump and the rest of the world. ... speed up peace talks in the continuous battle between Israel and Palestine. The world’s ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral ... Intellectual Property Office has granted Oramed a patent ... Exenatide". The patent covers Oramed,s invention of an ... is an incretin hormone that stimulates the secretion ...
(Date:5/8/2017)... May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO)., ... ("WRB"), a health care service center company based ... WRB specializes in relationship management programs for leading pharmaceutical ... WRB will join Envoy Health ... services for manufacturers, biotech firms, and other service companies. ...
(Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
Breaking Medicine Technology: